---
figid: PMC7880350__aging-13-202448-g008
figtitle: Schematic illustration the contribution of FGF23 induced by post-infarct
  heart failure to promoting renal fibrosis
organisms:
- NA
pmcid: PMC7880350
filename: aging-13-202448-g008.jpg
figlink: pmc/articles/PMC7880350/figure/f8/
number: F8
caption: 'Schematic illustration the contribution of FGF23 induced by post-infarct
  heart failure to promoting renal fibrosis. Myocardial infarction and heart failure
  up-regulates FGF23 in cardiomyocytes and increases FGF23 protein level in the kidneys
  through blood circulation. FGF23 binds FGFR4 in renal fibroblasts and then activates
  p-GSK3β/p-β-catenin/TGF-β/Vimentin/Collagen I signaling pathway to promote renal
  fibrosis. Intervention with FGF23 overexpression or FGFR antagonist or β-catenin
  inhibitor can change the degree of renal fibrosis. MI, myocardial infarction; HF,
  heart failure; FGF23, fibroblast growth factor 23; RBC, red blood cell; FGFR4, fibroblast
  growth factor receptor 4; p-GSK3β, phosphorylated glycogen synthase kinase-3 beta;
  p-β-catenin, phosphorylated beta-catenin; TGF-β, transforming growth factor-beta;
  PD173074, FGF receptor antagonist; BLU9931: FGFR4 antagonist; IGC001, β-catenin
  antagonist; ↑, activation; Т, inhibition.'
papertitle: Excessive fibroblast growth factor 23 promotes renal fibrosis in mice
  with type 2 cardiorenal syndrome.
reftext: Huixin Hao, et al. Aging (Albany NY). 2021 Jan 31;13(2):2982-3009.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9399964
figid_alias: PMC7880350__F8
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC7880350__F8
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7880350__aging-13-202448-g008.html
  '@type': Dataset
  description: 'Schematic illustration the contribution of FGF23 induced by post-infarct
    heart failure to promoting renal fibrosis. Myocardial infarction and heart failure
    up-regulates FGF23 in cardiomyocytes and increases FGF23 protein level in the
    kidneys through blood circulation. FGF23 binds FGFR4 in renal fibroblasts and
    then activates p-GSK3β/p-β-catenin/TGF-β/Vimentin/Collagen I signaling pathway
    to promote renal fibrosis. Intervention with FGF23 overexpression or FGFR antagonist
    or β-catenin inhibitor can change the degree of renal fibrosis. MI, myocardial
    infarction; HF, heart failure; FGF23, fibroblast growth factor 23; RBC, red blood
    cell; FGFR4, fibroblast growth factor receptor 4; p-GSK3β, phosphorylated glycogen
    synthase kinase-3 beta; p-β-catenin, phosphorylated beta-catenin; TGF-β, transforming
    growth factor-beta; PD173074, FGF receptor antagonist; BLU9931: FGFR4 antagonist;
    IGC001, β-catenin antagonist; ↑, activation; Т, inhibition.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FGF23
  - RN7SL263P
  - WAS
  - FGFR4
  - GSK3B
  - CTNNB1
  - TGFB1
  - TGFB2
  - TGFB3
  - COL6A1
  - COL6A2
  - COL6A3
  - COL6A5
  - COL6A6
  - COL7A1
  - COL8A1
  - COL8A2
  - COL9A1
  - COL9A2
  - COL9A3
  - COL10A1
  - COL11A1
  - COL11A2
  - COL12A1
  - COL13A1
  - COL14A1
  - COL15A1
  - COL16A1
  - COL17A1
  - COL18A1
  - COL19A1
  - COL20A1
  - COL21A1
  - COL22A1
  - COL23A1
  - COL24A1
  - COL25A1
  - COL26A1
  - COL27A1
  - COL28A1
  - COL1A1
  - COL1A2
  - COL4A1
  - COL4A2
  - COL4A3
  - COL4A4
  - COL4A5
  - COL4A6
  - COL5A1
  - COL5A2
  - COL5A3
  - PD173074
  - MI
  - Ischemia
  - fibrosis
---
